Evidence map›Paper›PMID 27729570›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors.

Hessel Peters-Sengers, Stefan P Berger, Martin B A Heemskerk, Doaa Al Arashi, Jaap J Homan van der Heide, Aline C Hemke, Ineke J M Ten Berge, Mirza M Idu, Michiel G H Betjes, Arjan D van Zuilen and 7 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 88 citations in OpenAlex.

  1. Optimizing the Use of Deceased Donor Kidneys at Risk of Discard: A Clinical Practice Guideline.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Guideline
  2. Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial.Journal of the American Society of Nephrology : JASN · 2026
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Adjusted Donor Age: A Clinical Score to Support Organ Acceptance Decisions in Deceased-Donor Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  15. Kidney Transplantation Improves Health-Related Quality of Life in Older Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  16. Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Article
  17. Review
  18. Review
  19. Living Donor Kidney Transplantation in Older Individuals: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  20. Temporal trends in the quality of deceased donor kidneys and kidney transplant outcomes in Europe: an analysis by the ERA-EDTA Registry.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Hessel Peters-SengersDepartments of Nephrology and h.peterssengers@amc.uva.nl.
Stefan P BergerDepartment of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
Martin B A HeemskerkNetherlands Organ Transplant Registry, Dutch Transplant Foundation, Leiden, The Netherlands.
Doaa Al ArashiDepartments of Nephrology and.
Jaap J Homan van der HeideDepartments of Nephrology and.
Aline C HemkeNetherlands Organ Transplant Registry, Dutch Transplant Foundation, Leiden, The Netherlands.
Ineke J M Ten BergeDepartments of Nephrology and.
Mirza M IduSurgery, Academic Medical Center, Amsterdam, The Netherlands.
Michiel G H BetjesDepartment of Nephrology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
Arjan D van ZuilenDepartment of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
Luuk B HilbrandsDepartment of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
Aiko P J de VriesDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Azam S NurmohamedDepartment of Nephrology, Vrije University Medical Center, Amsterdam, The Netherlands; and.
Maarten H ChristiaansDepartments of Nephrology and.
L W Ernest van HeurnSurgery, Maastricht University Medical Center, Maastricht, The Netherlands.
Johan W de FijterDepartment of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.
Frederike J BemelmanDepartments of Nephrology and.
Dutch Heart Registry · NLUniversity Medical Center Groningen · NLAcademic Medical Center · NLErasmus MC · NLMaastricht University · NLRadboud University Nijmegen · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing number of elderly patients (≥65 years) receive a donor kidney from elderly donors after brain death (DBD) or after circulatory death (DCD). These organs are allocated within the Eurotransplant Senior Program, but outcomes must be evaluated. From the Dutch Organ Transplantation Registry, we selected 3597 recipients (≥18 years) who received a first DBD or DCD kidney during 2002-2012, and categorized them as young or elderly recipients receiving a graft from either a young or elderly donor, stratified by donor type. In multiple logistic regression analysis, elderly recipients of elderly DCD kidneys experienced more delayed graft function and acute rejection than did elderly recipients of young DBD kidneys (odds ratios 10.43 [95% confidence interval (95% CI), 5.75 to 18.91] and 2.78 [95% CI, 1.35 to 5.73], respectively). In Cox regression analysis, elderly recipients of elderly DCD kidneys had a 5-year mortality risk higher than that of elderly recipients of young DBD kidneys (hazard ratio, 1.86; 95% CI, 1.15 to 3.02). Elderly recipients of elderly kidneys had a 5-year mortality rate comparable to that of waitlisted elderly patients remaining on dialysis. Among elderly recipients, 63.8% of those who received elderly DCD kidneys, 45.5% of those who received elderly DBD kidneys, and approximately 26% of those who received young DBD or DCD kidneys had an eGFR<30 ml/min per 1.73 m

Indexed as

Kidney TransplantationAgedAge FactorsCadaverDonor SelectionFemaleHumansMaleMiddle AgedTissue and Organ ProcurementDonation after brain deathDonation after circulatory deathElderly donorsElderly recipientsEurotransplant Senior Programkidney transplantation

Identifiers

PMID27729570
PMCPMC5280003
OpenAlexW2531370047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.